Compare Medpace Holdings Inc (MEDP) vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? Medpace Holdings Inc trades at $519.93 (market cap $15.08B), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.92. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF nearer its low. Which is the better fit depends on your goals.
| MEDP | SJNK | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $620.59 | $25.63 |
52-Week Low | $308.88 | $24.75 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
SJNK trades at $24.92 with no price change in the last 24 hours, showing technical bearish signals from moving averages while oscillators remain neutral. The ETF maintains consistent dividend payments with recent distributions of $0.14-$0.15 per share. Current technical analysis indicates bearish momentum with key support and resistance clustered around $25 levels.
The short-term high-yield bond ETF faces headwinds from potential yield normalization after benefiting from falling rates. Analyst sentiment appears cautious with recent bearish ratings citing exhausted tailwinds. Key risks include interest rate sensitivity and credit spread volatility in the junk bond market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF
SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →
